注射吸毒者中的社区获得性金黄色葡萄球菌菌血症:英格兰2017-2020年全国队列研究
研究链接英格兰三个全国数据集,纳入2017年1月1日至2020年12月31日住院的社区获得性金黄色葡萄球菌菌血症(CA-SAB)患者,比较注射吸毒者(PWID)与非PWID的30天全因死亡和90天再入院。10045例CA-SAB中1612例(16.0%)为PWID;无感染性心内膜炎时PWID死亡 odds 更低(aOR 0.47),90天再入院 odds 也更低(aOR 0.79)。
要点
- 10045例CA-SAB中PWID占1612例(16.0%)。
- 无感染性心内膜炎者,PWID较非PWID的30天死亡 odds 更低(aOR 0.47)。
- PWID较非PWID的90天再入院 odds 更低(aOR 0.79)。
核心结论
- 在英格兰大型CA-SAB队列中,无感染性心内膜炎时PWID死亡 odds 低于非PWID,90天再入院 odds 也低于非PWID;研究凸显PWID在CA-SAB患者中比例过高。
研究设计与样本
- 链接英格兰三个全国数据集,纳入2017年1月1日至2020年12月31日住院的CA-SAB患者。
- 用ICD-10中「阿片类使用所致精神与行为障碍」编码F11识别PWID。
- 采用多变量logistic回归估计PWID与30天全因死亡及90天再入院的校正比值比(aOR)。
主要发现
- 10045例CA-SAB中1612例(16.0%)为PWID。
- 796例(7.9%)在CA-SAB入院后30天内死亡,1189例(11.8%)在90天内再入院。
- 无感染性心内膜炎者中,PWID较非PWID的30天死亡 odds 更低(aOR 0.47 [95%CI .33-.68];P < .001)。
- 伴感染性心内膜炎者中,PWID与CA-SAB病死率无关联(aOR 1.40 [95%CI .87-2.25];P = .163)。
- PWID较非PWID的90天再入院 odds 更低(aOR 0.79 [95%CI .65-.95];P = .011)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: People who inject drugs (PWID) are at increased risk of community-acquired Staphylococcus aureus bacteremia (CA-SAB), but little is known about clinical outcomes of CA-SAB in PWID compared with the wider population of patients with CA-SAB. METHODS: Three national datasets were linked to provide clinical and mortality data on patients hospitalized with CA-SAB in England between 1 January 2017 and 31 December 2020. PWID were identified using the International Classification of Diseases, Tenth Revision code for "mental health and behavioral disorder due to opioid use" (F11). Multivariable logistic regression was used to estimate adjusted odds ratios (aORs) for associations of PWID with 30-day all-cause mortality and 90-day hospital readmission. RESULTS: In 10 045 cases of CA-SAB, 1612 (16.0%) were PWID. Overall, 796 (7.9%) patients died within 30 days of CA-SAB admission and 1189 (11.8%) patients were readmitted to hospital within 90 days of CA-SAB. In those without infective endocarditis, there was strong evidence of lower odds of mortality among PWID compared with non-PWID (aOR, 0.47 [95% confidence interval {CI}: .33-.68]; P < .001), whereas there was no association in CA-SAB case fatality with endocarditis (aOR, 1.40 [95% CI: .87-2.25]; P = .163). PWID were less likely to be readmitted within 90 days of CA-SAB (aOR, 0.79 [95% CI: .65-.95]; P = .011). CONCLUSIONS: In this large cohort study of patients with CA-SAB in England, PWID had lower odds of death in the absence of endocarditis and lower odds of readmission within 90 days compared to non-PWID patients. This study highlights the overrepresentation of PWID among patients with CA-SAB nationally.
引用
- McGuire E, Collin SM, Brown CS, et al. Community-Acquired Staphylococcus aureus Bacteremia Among People Who Inject Drugs: A National Cohort Study in England, 2017-2020. Clin Infect Dis. 2024. PMID: 38315893. doi:10.1093/cid/ciae056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。